Genomic Editing of a Pathogenic Sequence Variant in <i>ACTA2</i> Rescues Multisystemic Smooth Muscle Dysfunction Syndrome in Mice

This study demonstrates the effectiveness of adenine base editing to treat multisystemic smooth muscle dysfunction syndrome and restore aortic smooth muscle function. By correcting the <i>ACTA2</i> R179H sequence variant, the pathogenic phenotypic shift in SMCs was prevented, key aortic smooth muscle functions were restored, and life-threatening aortic dilation and dissection were mitigated in humanized mice. These findings underscore the promise of gene-editing therapies in addressing the underlying genetic causes of smooth muscle disorders and offer a potential transformative treatment for patients facing severe vascular complications.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-05-16
DOI
https://doi.org/10.1161/circulationaha.125.074218
Citations
6
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
4.84
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genomic Editing of a Pathogenic Sequence Variant in ACTA2 Rescues Multisystemic Smooth Muscle Dysfunction Syndrome in Mice

Yu Zhang, Peiheng Gan, John McAnally, Lei Guo et al.
6 citations
Circulation
CRISPR and Genetic Engineering
4.84
article

Genomic Editing of a Pathogenic Sequence Variant in ACTA2 Rescues Multisystemic Smooth Muscle Dysfunction Syndrome in Mice

Yu Zhang, Peiheng Gan, John McAnally, Lei Guo, Dileep Karri, Cameron M. Macdonald, Lin Xu, Eric N. Olson, Efrain Sanchez‐Ortiz, Wei Hong Tan, Hui Li, Ning Liu, Zhi‐Sheng Xu, Qianqian Ding
article en
6 citations

Abstract

This study demonstrates the effectiveness of adenine base editing to treat multisystemic smooth muscle dysfunction syndrome and restore aortic smooth muscle function. By correcting the <i>ACTA2</i> R179H sequence variant, the pathogenic phenotypic shift in SMCs was prevented, key aortic smooth muscle functions were restored, and life-threatening aortic dilation and dissection were mitigated in humanized mice. These findings underscore the promise of gene-editing therapies in addressing the underlying genetic causes of smooth muscle disorders and offer a potential transformative treatment for patients facing severe vascular complications.

CirculationVol. 152(7)
Southwestern Medical Center (US), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Openalex Percentile: Top 5%
CRISPR and Genetic Engineering
4.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Genomic Editing of a Pathogenic Sequence Variant in <i>ACTA2</i> Rescues Multisystemic Smooth Muscle Dysfunction Syndrome in Mice — Yu Zhang, Peiheng Gan, et al. · Circulation (2025) | TGRS Research Map | TGRS